Open AccessPlanned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)
Author(s) -
Anna Kalff,
Tiffany Khong,
Malarmathy Ramachandran,
P. Joy Ho,
Peter Mollee,
James D’Rozario,
Kerry Taylor,
Jane Estell,
Debabrata Bandyopadhyay,
Roslyn A. Kemp,
Andrew J Mitchell,
John Reynolds,
Nola Kennedy,
Hang Quach,
Andrew Spencer
Publication year - 2021
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.278655
Subject(s) - pomalidomide , lenalidomide , dexamethasone , multiple myeloma , medicine , refractory (planetary science) , oncology , biology , astrobiology